|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Journal of Lipid Research, Vol. 44, 601-611, March 2003
Copyright © 2003 by Lipid Research, Inc.
me UMR Physiologie et Physiopathologie, Université Pierre et Marie Curie, case courrier 256, Bâtiment A, 5, étage, 7 quai Saint Bernard, 75252 Paris Cedex 5, France
1 To whom correspondence should be addressed. e-mail: arthur.brouillet{at}snv.jussieu.fr
There is good evidence that the n-3 polyunsaturated fatty acids (PUFAs) in fish oil have antiinflammatory effects and reduce the pathogenesis of atherosclerosis. However, the mechanisms underlying these actions are largely unknown. This study was designed to investigate the effects of membrane incorporation of two major components of fish oil [eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA)], on rat smooth muscle cells (SMCs) activation induced by interleukin-1ß (IL1ß). We compared their effects with those of n-6 arachidonic acid (AA). Expression of vascular cell adhesion molecule-1 and monocyte chemoattractant protein-1 adhesion molecules involved in SMCs migration was enhanced by AA, whereas EPA and DHA had no similar effects. We established that AA potentiates IL1ß-induced expression of the type IIA secreted phospholipase A2 (sPLA2) gene, whereas EPA and DHA reduce this stimulation. EPA and DHA also abolished proinflammatory prostaglandin PGE2 production by inhibiting the IL1ß-induced production of cyclooxygenase-2 (COX-2) mRNA. Much interest was then focused on three transcriptional factors implicated in inflammation control and especially in modulating rat sPLA2 and COX-2 gene transcription: nuclear factor-
B, CCAAT/enhancer binding protein ß, and E26 transformation-specific-1. electrophoretic mobility shift assay revealed that the binding activity of all three factors was increased by AA and reduced (or not affected) by n-3 PUFA.
These results indicate that EPA and DHA act in opposition to AA by modulating various steps of the inflammatory process induced by IL1ß, probably by reducing mitogen-activated protein kinase p42/p44 activity.
Abbreviations: AA, arachidonic acid; C/EBP, CCAAT/enhancer binding protein; COX-2, cyclooxygenase-2; DHA, docosahexaenoic acid; EMSA, electrophoretic mobility shift assay; EPA, eicosapentaenoic acid; ERK, extracellular signal-regulated kinase; IL1ß, interleukin-1ß; MAPK, mitogen-activated protein kinase; MCP-1, monocyte chemoattractant protein-1; MEK, MAPK kinase; SMC, smooth muscle cell; sPLA2, secreted phospholipase A2; VCAM-1, vascular cell adhesion molecule-1; ZAL, Z-IE(o-t-butyl)A-leucinal
Supplementary key words eicosapentaenoic acid docosahexaenoic acid type IIA secretory phospholipase A2
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
M. M. Diaz Encarnacion, G. M. Warner, C. E. Gray, J. Cheng, H. K. H. Keryakos, K. A. Nath, and J. P. Grande Signaling pathways modulated by fish oil in salt-sensitive hypertension Am J Physiol Renal Physiol, June 1, 2008; 294(6): F1323 - F1335. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Delbosc, M. Glorian, A.-S. Le Port, G. Bereziat, M. Andreani, and I. Limon The Benefit of Docosahexanoic Acid on the Migration of Vascular Smooth Muscle Cells Is Partially Dependent on Notch Regulation of MMP-2/-9 Am. J. Pathol., May 1, 2008; 172(5): 1430 - 1440. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. Poulsen, P. J. Moughan, and M. C. Kruger Long-Chain Polyunsaturated Fatty Acids and the Regulation of Bone Metabolism Experimental Biology and Medicine, November 1, 2007; 232(10): 1275 - 1288. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Brant, W. Guan, P. Tithof, and R. L. Caruso Gestation Age-Related Increase in 50-kDa Rat Uterine Calcium-Independent Phospholipase A2 Expression Influences Uterine Sensitivity to Polychlorinated Biphenyl Stimulation Biol Reprod, May 1, 2006; 74(5): 874 - 880. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Hagiwara, Y. Makita, L. Gu, M. Tanimoto, M. Zhang, S. Nakamura, S. Kaneko, T. Itoh, T. Gohda, S. Horikoshi, et al. Eicosapentaenoic acid ameliorates diabetic nephropathy of type 2 diabetic KKAy/Ta mice: Involvement of MCP-1 suppression and decreased ERK1/2 and p38 phosphorylation Nephrol. Dial. Transplant., March 1, 2006; 21(3): 605 - 615. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Jia, H.-R. Zhou, Y. Shi, and J. J. Pestka Docosahexaenoic Acid Consumption Inhibits Deoxynivalenol-Induced CREB/ATF1 Activation and IL-6 Gene Transcription in Mouse Macrophages J. Nutr., February 1, 2006; 136(2): 366 - 372. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Calviello, F. Di Nicuolo, S. Gragnoli, E. Piccioni, S. Serini, N. Maggiano, G. Tringali, P. Navarra, F. O. Ranelletti, and P. Palozza n-3 PUFAs reduce VEGF expression in human colon cancer cells modulating the COX-2/PGE2 induced ERK-1 and -2 and HIF-1{alpha} induction pathway Carcinogenesis, December 1, 2004; 25(12): 2303 - 2310. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |